Daniel Jacobson is an Analyst, Sagard Healthcare at Sagard and joined the firm in 2022. As a member of Sagard Healthcare, Daniel invests in approved and commercialized biopharmaceuticals, diagnostics, and medical devices that are protected by strong intellectual property. He is responsible for all aspects of the investment process, including origination, due diligence, execution, and portfolio management. Daniel is based in Toronto, Canada.
Prior to Sagard, Daniel was an Investment Banking Analyst at Lazard, where he was involved in several M&A transactions for a diversified client base.
Daniel holds a BMSc with an Honor’s Specialization in Interdisciplinary Medical Sciences from Western University and an HBA from Ivey Business School.